Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cara Therapeutics, Inc.    CARA

CARA THERAPEUTICS, INC.

(CARA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/07/2021 04/08/2021 04/09/2021 04/12/2021 04/13/2021 Date
26.53(c) 27.47(c) 29.19(c) 28.36(c) 27.49(c) Last
11 048 999 1 676 566 2 393 124 1 107 665 1 034 516 Volume
-2.28% +3.54% +6.26% -2.84% -3.07% Change
More quotes
Financials (USD)
Sales 2021 31,3 M - -
Net income 2021 -96,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -14,4x
Yield 2021 -
Sales 2022 98,3 M - -
Net income 2022 -43,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -35,0x
Yield 2022 -
Capitalization 1 371 M 1 371 M -
Capi. / Sales 2021 43,8x
Capi. / Sales 2022 13,9x
Nbr of Employees 80
Free-Float 83,8%
More Financials
Company
Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The Company operates through the activities related to the discovery and development of... 
Sector
Biotechnology & Medical Research
Calendar
04/14 | 02:15pmPresentation
More about the company
Notations Surperformance© of Cara Therapeutics, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about CARA THERAPEUTICS, INC.
04/07Cara Therapeutics to Present at the 20th Annual Needham Healthcare Conference
GL
04/07CARA THERAPEUTICS  : April 2021 Investor Fact Sheet
PU
04/07CARA THERAPEUTICS  : 2021 R&D Day Presentation
PU
04/07CARA THERAPEUTICS  : March 2021 Corporate Presentation
PU
04/06AFTER HOURS WATCH LIST SCORECARD : Ilmn, cara, uctt
MT
04/06Illumina, Cara Therapeutics rise; Greenbrier, Paychex fall
AQ
04/06SECTOR UPDATE : Health Care Stocks Fading Late
MT
04/06SECTOR UPDATE : Health Care Stocks Largely Staying on Positive Ground
MT
04/06Wall Street Inches Lower Pre-Bell, Consolidating After Record Rises
MT
04/05MT NEWSWIRES AFTER HOURS WATCH LIST : Ilmn, cara, uctt
MT
04/05Cara Therapeutics to Join S&P SmallCap 600; Stock Jumps 13% After Hours
MT
03/31CARA THERAPEUTICS  : to Host Virtual Research and Development Event on April 7, ..
AQ
03/30CARA THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
03/30CARA THERAPEUTICS'  : Marketing Authorization Filing for Difelikefalin Accepted ..
MT
03/30VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted ..
GL
More news
News in other languages on CARA THERAPEUTICS, INC.
03/30Bourse Zurich: le SMI termine sur une note positive, au-dessus des 11'100 poi..
03/30Bourse Zurich: le SMI tente de se maintenir dans le vert
03/30Bourse Zurich: le SMI tente de se ressaisir
03/30Bourse Zurich: le SMI devrait tenter de se ressaisir
03/30Vifor-Joint Venture und Partner Cara kommen mit EU-Zulassungsantrag weiter
More news
Chart CARA THERAPEUTICS, INC.
Duration : Period :
Cara Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARA THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 35,13 $
Last Close Price 27,49 $
Spread / Highest target 71,0%
Spread / Average Target 27,8%
Spread / Lowest Target -23,6%
EPS Revisions
Managers and Directors
NameTitle
Derek T. Chalmers President, Chief Executive Officer & Director
Thomas Reilly Chief Financial & Accounting Officer
Frèdèrique Menzaghi Chief Scientific Officer, Senior VP-R&D
Joana Goncalves Chief Medical Officer
Scott M. Terrillion Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capitalization (M$)
CARA THERAPEUTICS, INC.81.69%1 371
GILEAD SCIENCES, INC.10.99%81 700
VERTEX PHARMACEUTICALS INCORPORATED-8.63%55 890
WUXI APPTEC CO., LTD.-0.16%50 134
REGENERON PHARMACEUTICALS, INC.-2.13%49 681
BIONTECH SE59.03%31 311